Your browser doesn't support javascript.
loading
Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis.
McDonald, Patrick P; Leifer, Franziska Graf; Basso, Jessica; Lasala, Dan; Li, Dedong; Chen, Kuan-Ju; Zhang, Jimin; Perkins, Walter R; Cipolla, David C.
Afiliación
  • McDonald PP; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Leifer FG; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Basso J; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Lasala D; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Li D; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Chen KJ; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Zhang J; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Perkins WR; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
  • Cipolla DC; Department of Research, Insmed Incorporated, Bridgewater, NJ, United States.
Front Immunol ; 14: 1231047, 2023.
Article en En | MEDLINE | ID: mdl-37638021
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos